Sensei Bio

Sensei Bio

Biotechnology, 1405 Research BLVD, Rockville, Maryland, 20850, United States, 11-50 Employees

senseibio.com

  • twitter
  • LinkedIn

phone no Phone Number: 12*********

Who is SENSEI BIO

Sensei Biotherapeutics is an immuno-oncology company that is dedicated to understanding and selectively interacting with the tumor microenvironment in order to tilt the immune system agai...

Read More

map
  • 1405 Research BLVD, Rockville, Maryland, 20850, United States Headquarters: 1405 Research BLVD, Rockville, Maryland, 20850, United States
  • 1999 Date Founded: 1999
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from SENSEI BIO

Sensei Bio Org Chart and Mapping

Employees

Samindhi Wu

Associate Director, Technical Operations

Zaide Ibic

Research Associate 2

Donelson Smith

Director, Sensei Biotherapeutics

Cassie Fielding

Consulting Research Technician II

Zhigang Jiang

Director, Neurodegenerative Diseases

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Sensei Bio

Answer: Sensei Bio's headquarters are located at 1405 Research BLVD, Rockville, Maryland, 20850, United States

Answer: Sensei Bio's phone number is 12*********

Answer: Sensei Bio's official website is https://senseibio.com

Answer: Sensei Bio's revenue is $25 Million to $50 Million

Answer: Sensei Bio's SIC: 2834

Answer: Sensei Bio has 11-50 employees

Answer: Sensei Bio is in Biotechnology

Answer: Sensei Bio contact info: Phone number: 12********* Website: https://senseibio.com

Answer: Sensei Biotherapeutics is an immuno-oncology company that is dedicated to understanding and selectively interacting with the tumor microenvironment in order to tilt the immune system against cancer. We are leveraging our TMAbTM platform to develop highly selective therapeutics that have the potential to alter the relationship between host immune cells and cancer so that the tumor is recognized and treated as if it were an infection. Our team is comprised of lifelong learners striving for insight at the intersection of immunology, oncology and biology. We are driven to apply our scientific curiosity to the critical needs faced daily by people who are diagnosed with cancer and the physicians who treat them. We stay humble, always follow the data, and believe that our deep knowledge of cancer biology, the tumor microenvironment, and immunology will lead us to effective therapies.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access